Key result
Active systemic lupus erythematosus was associated with significantly elevated total cholesterol, LDL, and triglycerides, and decreased HDL compared to inactive SLE and healthy controls (P<0.001).
Why the study?
Is active systemic lupus erythematosus associated with dyslipidemia compared to inactive disease and healthy controls?
Cross-Sectional (n=80)
Is active systemic lupus erythematosus associated with dyslipidemia compared to inactive disease and healthy controls?
p-value: p=< 0.001
Active systemic lupus erythematosus is associated with a pro-atherogenic lipid profile, highlighting increased cardiovascular risk in this population.
No takes yet. Share an insight, caveat, or question.
Dyslipidemia tracks with SLE activity; leaves open whether targeted lipid management improves CV outcomes in active disease.
Khalil et al. (2018) conducted a cross-sectional in Systemic Lupus Erythematosus (n=80). Active systemic lupus erythematosus vs. Inactive systemic lupus erythematosus and healthy controls was evaluated on Total cholesterol, LDL, HDL, and triglyceride levels (p=< 0.001). Active systemic lupus erythematosus was associated with significantly elevated total cholesterol, LDL, and triglycerides, and decreased HDL compared to inactive SLE and healthy controls (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: